Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Clinical trial NCT04266665 · COMPLETED

Trial details

NCT number: NCT04266665
Sponsor: Georgia Tsaousi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Brain Tumor Metabolic Disturbance Inflammatory Response Oxygen Deficiency

Start date: 2020-03-12
Primary completion: 2023-10-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.